NEW YORK, Dec. 05, 2016 -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Alere Inc. (“Alere” or the “Company”) (NYSE:ALR) and certain of its officers, and is on behalf of shareholders who purchased or otherwise acquired Alere securities between February 29, 2012 and November 4, 2016 both dates inclusive (the “Class Period”). Such investors are advised to join this case by visiting the firm’s site: www.bgandg.com/alr.
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).
The Complaint alleges that throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Alere’s wholly-owned subsidiary, Arriva Medical, LLC (“Arriva”), was submitting claims to Medicare for deceased patients; (2) the above-mentioned conduct subjected Arriva to revocation of its Medicare enrollment; and (3) consequently, defendants’ statements about the Company’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.
On November 4, 2016, Alere announced that the Centers for Medicare and Medicaid Services alleged that Arriva Medical, Alere’s subsidiary, had submitted claims for 211 deceased patients for over five years, and thus withdrew Arriva’s Medicare enrollment. Following this news, Alere stock dropped $6.13 per share or roughly 14.5% on November 4, 2016.
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/alr or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Alere you have until January 13, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | [email protected]


Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers 



